| Literature DB >> 18447379 |
Essa Hu1, Andrew Tasker, Ryan D White, Roxanne K Kunz, Jason Human, Ning Chen, Roland Bürli, Randall Hungate, Perry Novak, Andrea Itano, Xuxia Zhang, Violeta Yu, Yen Nguyen, Yanyan Tudor, Matthew Plant, Shaun Flynn, Yang Xu, Kristin L Meagher, Douglas A Whittington, Gordon Y Ng.
Abstract
Inhibition of c-Kit has the potential to treat mast cell associated fibrotic diseases. We report the discovery of several aminoquinazoline pyridones that are potent inhibitors of c-Kit with greater than 200-fold selectivity against KDR, p38, Lck, and Src. In vivo efficacy of pyridone 16 by dose-dependent inhibition of histamine release was demonstrated in a rodent pharmacodynamic model of mast cell activation.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18447379 DOI: 10.1021/jm800188g
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446